Skip to main content
Equibles

SHUKRAPHAR · Shukra Pharmaceuticals Limited · Financials

Use SHUKRAPHAR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SHUKRAPHAR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
82.25 INR +0.07 (+0.09%) At close · Nov 13
Rebalance outlook locked
Market Cap
36.16B INR
Shares
439.61M
Volume · Nov 13 386K Avg daily vol (3M) 610.06K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
567.27M
FY2026
Net Income
220.59M
FY2026
Operating Cash Flow
39.31M
FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026
INR 1.13B 567.27M
INR 40.45M 34.43M
INR 13.02M 10.93M
INR 629.13M 287.87M
INR 172.73M 67.28M
INR 106.96M 220.59M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.